非活动性HBsAg携带状态抗病毒治疗的利与弊
Pros and cons of anti-HBV for inactive HBsAg carrier
摘要
为达到WHO 2030年消除病毒性肝炎的目标,目前各国家/地区(美国、欧洲、亚太、中国)对非活动性乙型肝炎病毒(HBV)表面抗原(HBsAg)携带状态(IHC)的诊治提出了并非完全一致的推荐意见。我国IHC患者约3 096万,我国《慢性乙型肝炎防治指南》针对IHC给出了更为积极的推荐意见。本文就IHC抗病毒治疗的利弊对已有的临床研究结果展开综述。
作者
曾达武
朱月永
Zeng Dawu;Zhu Yueyong
出处
《临床内科杂志》
CAS
2023年第12期802-806,共5页
Journal of Clinical Internal Medicine
参考文献12
-
1Chen C.-J.,Yang H. -I.,Su J.,王铮(译),陈云茹(校).血清乙型肝炎病毒DNA水平的生物学梯度与肝细胞肝癌的风险性相关[J].世界核心医学期刊文摘（胃肠病学分册）,2006,2(6):1-1. 被引量：222
-
2Dake Zhang,Ke Zhang,Urlike Protzer,Changqing Zeng.HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site[J].Journal of Clinical and Translational Hepatology,2021,9(3):399-408. 被引量：4
-
3Ming-Hui Li,Yao Xie,Lu Zhang,Yao Lu,Ge Shen,Shu-Ling Wu,Min Chang,Cai-Qin Mu,Lei-Ping Hu,Wen-Hao Hua,Shu-Jing Song,Shu-Feng Zhang,Jun Cheng,Dao-Zhen Xu.Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a[J].World Journal of Hepatology,2016,8(15):637-643. 被引量：19
-
4史罗明,周根法,孙冬林.聚乙二醇干扰素-α-2a治疗血清低水平HBsAg阳性的慢性乙型肝炎患者临床结局预测研究[J].实用肝脏病杂志,2018,21(4):565-568. 被引量：17
-
5赵海东,陈灵峰,林巧欣,李艺芳.聚乙二醇干扰素α短期治疗HBsAg水平极低的非活动性HBsAg携带者的疗效观察[J].肝脏,2020,25(9):937-939. 被引量：10
-
6周淋淋,秦波.聚乙二醇干扰素治疗非活动性乙型肝炎病毒表面抗原携带者疗效预测[J].中国感染与化疗杂志,2020,20(4):374-378. 被引量：8
-
7陈曦,赵文静,孙岩,殷海燕.基线HBsAg水平对聚乙二醇干扰素α-2b治疗慢性乙型肝炎效果的预测价值[J].临床肝胆病杂志,2020,36(8):1723-1726. 被引量：6
-
8中华医学会肝病学分会,尤红,庄辉,孙亚朦,窦晓光,任红,南月敏,徐小元,段钟平,侯金林,魏来,贾继东,王福生.扩大慢性乙型肝炎抗病毒治疗的专家意见[J].中华肝脏病杂志,2022,30(2):131-136. 被引量：93
-
9Bortolotti F.,Guido M.,Bartolacci S.,王铮.慢性乙型肝炎患儿e抗原清除后调查:一项29年的纵向研究[J].世界核心医学期刊文摘（胃肠病学分册）,2006,2(9):49-50. 被引量：7
-
10Hong You,Fusheng Wang,Taisheng Li,Xiaoyuan Xu,Yameng Sun,Yuemin Nan,Guiqiang Wang,Jinlin Hou,Zhongping Duan,Lai Wei,Jidong Jia,Hui Zhuang,Chinese Society of Hepatology,Chinese Medical Association,Chinese Society of Infectious Diseases,Chinese Medical Association.Guidelines for the Prevention and Treatment of Chronic Hepatitis B(version 2022)[J].Journal of Clinical and Translational Hepatology,2023,11(6):1425-1442. 被引量：6
二级参考文献90
-
1Peng Hu,Jia Shang,Wenhong Zhang,Guozhong Gong,Yongguo Li,Xinyue Chen,Jianning Jiang,Qing Xie,Xiaoguang Dou,Yongtao Sun,Yufang Li,Yingxia Liu,Guozhen Liu,Dewen Mao,Xiaoling Chi,Hong Tang,Xiaoou Li,Yao Xie,Xiaoping Chen,Jiaji Jiang,Ping Zhao,Jinlin Hou,Zhiliang Gao,Huimin Fan,Jiguang Ding,Dazhi Zhang,Hong Ren.HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog:New Switch Study[J].Journal of Clinical and Translational Hepatology,2018,6(1):25-34. 被引量：87
-
2Xie-Er Liang,Yong-Peng Chen.Clinical Application of Vibration Controlled Transient Elastography in Patients with Chronic Hepatitis B[J].Journal of Clinical and Translational Hepatology,2017,5(4):368-375. 被引量：13
-
3Meetings[J].World Journal of Gastroenterology,2010,16(2). 被引量：28
-
4Gerald C Kimbi,Anna Kramvis,Michael C Kew.Integration of hepatitis B virus DNA into chromosomal DNA during acute hepatitis B[J].World Journal of Gastroenterology,2005,11(41):6416-6421. 被引量：12
-
5European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection[J]. Journal of Hepatology . 2012 (1)
-
6Chia-Ming Chu,Shao-Jen Hung,Justin Lin,Dar-In Tai,Yun-Fan Liaw.Natural history of hepatitis b e antigen to antibody seroconversion in patients with normal serum aminotransferase levels[J].The American Journal of Medicine.2004(12)
-
7Henry Lik–Yuen Chan,Vincent Wai–Sun Wong,Ada Mei–Ling Tse,Chi–Hang Tse,Angel Mei–Ling Chim,Hoi–Yun Chan,Grace Lai–Hung Wong,Joseph Jao–Yiu Sung.Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment Response[J].Clinical Gastroenterology and Hepatology.2007(12)
-
8Teerha Piratvisuth,Patrick Marcellin,Matei Popescu,Hans-Peter Kapprell,Vivien Rothe,Zhi-Meng Lu.Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients[J].Hepatology International.2013(2)
-
9Henry Lik-Yuen Chan,Alex Thompson,Michelle Martinot-Peignoux,Teerha Piratvisuth,Markus Cornberg,Maurizia Rossana Brunetto,Hans L. Tillmann,Jia-Horng Kao,Ji-Dong Jia,Heiner Wedemeyer,Stephen Locarnini,Harry L.A. Janssen,Patrick Marcellin.Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report[J].Journal of Hepatology.2011(5)
-
10Yao-Shih Hsu,Rong-Nan Chien,Chau-Ting Yeh,I-Shyan Sheen,Hung-Yi Chiou,Chia-Ming Chu,Yun-Fan Liaw.Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B[J].Hepatology.2002(6)
共引文献475
-
1陈慧.长效干扰素治疗核苷经治慢性乙肝患者的疗效观察[J].智慧健康,2020(19):146-147.
-
2韩津津,邹金兵,周潞荣.艾滋病合并乙型肝炎双重感染的流行现状与研究进展[J].世界最新医学信息文摘,2020(24):112-114.
-
3中国医师协会介入医师分会临床诊疗指南专委会,滕皋军,刘嵘,朱海东,贾中芝,仲斌演,范文哲,赵明,王健,靳勇,陆建,梁斌,段峰,夏冬东,杨国威.中国肝细胞癌经动脉化疗栓塞(TACE)治疗临床实践指南(2023年版)[J].中华医学杂志,2023,103(34):2674-2694. 被引量：8
-
4戴二黑,郭心如,王继涛,胡庆刚,李加欢,唐奇远,祖红梅,宦徽,王岩,郜玉峰,胡国启,李卫,刘贞君,马前坡,宋有良,杨江华,朱艳,黄顺东,孟忠吉,白冰,陈友鹏,高畅,黄明星,金少琴,鲁萌芝,许哲,张倩华,郑双,曾庆磊,祁小龙.肝硬化的病因及防治现状调查[J].中华医学杂志,2023,103(12):913-919. 被引量：6
-
5连立超,范子玥,张昕,白丽.尿KIM-1、NGAL、RBP联合检测在慢性乙肝患者早期肾损伤中的预测价值[J].中华临床医师杂志（电子版）,2023,17(4):414-418.
-
6殷建华,陈劲松,曹广文.HBV相关HCC的家庭聚集性研究[J].肿瘤,2007,27(3):244-246. 被引量：1
-
7孟永洁,杨晓秦,李德霞,杜玲玲.乙肝后肝硬化高危人群的治疗起点争议与一、二级预防干预[J].卫生职业教育,2007,25(10):137-139.
-
8周霞,邓国宏,向德栋,王宇明.乙型肝炎病毒复制水平对原发性肝癌发病的影响[J].现代生物医学进展,2008,8(4):661-663. 被引量：14
-
9刘静,邓子德,吴跃.慢性乙型病毒性肝炎和肝炎后肝硬化患者HBV DNA水平自发性下降的临床研究——附264例报告[J].新医学,2008,39(8):501-503. 被引量：5
-
10陈杰,贾继东.亚太地区肝病学会2008年《慢性乙型肝炎治疗共识》导读[J].传染病信息,2008,21(4):193-195. 被引量：3
